Nov 4 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2022 Sep 30, 2021 Mar 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 293 mln 253 mln 775 mln
(+15.4 pct) (+2.4 pct) (+19.7 pct)
Operating loss 54 mln loss 136 mln 3 mln
Recurring loss 129 mln loss 188 mln loss 95 mln
Net loss 136 mln loss 199 mln loss 120 mln
EPS loss 14.62 yen loss 21.40 yen loss 12.88 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T